Evicenter
MarkdownMedical informationP&T meetings
AD109 (aroxybutynin-atomoxetine)

Obstructive sleep apnea

Also known as Oxnimbi
Manufacturer
Apnimed
Launch
Not announced
Last updated
183 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Positional therapy

3 evidence topics · 3 sources

ERS guideline: vibratory positional therapy or CPAP in mild or moderate position-dependent OSA (conditional recommendation, very low certainty of evidence), hypopnea scoring rule not stated